Optimization of the medium perfusion rate in a packed-bed bioreactor charged with CHO cells

In the present study, the optimal medium perfusion rate to be used for the continuous culture of a recombinant CHO cell line in a packed-bed bioreactor made of Fibra-Cel® disk carriers was determined. A first-generation process had originally been designed with a high perfusion rate, in order to rapidly produce material for pre-clinical and early clinical trials. It was originally operated with a perfusion of 2.6 vvd during production phase in order to supply the high cell density (2.5×107 cell ml−1 of packed-bed) with sufficient fresh medium. In order to improve the economics of this process, a reduction of the medium perfusion rate by −25% and −50% was investigated at small-scale. The best option was then implemented at pilot scale in order to further produce material for clinical trials with an improved second-generation process. With a −25% reduction of the perfusion rate, the volumetric productivity was maintained compared to the first-generation process, but a −30% loss of productivity was obtained when the medium perfusion rate was further reduced to −50% of its original level. The protein quality under reduced perfusion rate conditions was analyzed for purity, N-glycan sialylation level, abundance of dimers or aggregates, and showed that the quality of the final drug substance was comparable to that obtained in reference conditions. Finally, a reduction of −25% medium perfusion was implemented at pilot scale in the second-generation process, which enabled to maintain the same productivity and the same quality of the molecule, while reducing costs of media, material and manpower of the production process. For industrial applications, it is recommended to test whether and how far the perfusion rate can be decreased during the production phase – provided that the product is not sensitive to residence time – with the benefits of reduced cost of goods and to simplify manufacturing operations.

[1]  C A Heath,et al.  High-density hybridoma perfusion culture , 1997, Applied biochemistry and biotechnology.

[2]  Nigel Jenkins,et al.  Getting the glycosylation right: Implications for the biotechnology industry , 1996, Nature Biotechnology.

[3]  J M Piret,et al.  Glucose-based optimization of CHO-cell perfusion cultures. , 2001, Biotechnology and bioengineering.

[4]  A Lyddiatt,et al.  Molecular integrity of monoclonal antibodies produced by hybridoma cells in batch culture and in continuous‐flow culture with integrated product recovery , 1993, Biotechnology and bioengineering.

[5]  T. Sugiura,et al.  Dynamics of recombinant protein production by mammalian cells in immobilized perfusion culture , 1998 .

[6]  J. Auniņš,et al.  Large-scale mammalian cell culture. , 1997, Current opinion in biotechnology.

[7]  George T. L. Land.  Grow or Die: The Principle of Transformation. , 1973 .

[8]  R. Lemieux,et al.  Long‐term perfusion culture of hybridoma: A “grow or die” cell cycle system , 1991, Biotechnology and bioengineering.

[9]  H. Chang,et al.  High‐density continuous cultures of hybridoma cells in a depth filter perfusion system , 1994, Biotechnology and bioengineering.

[10]  A. Bull,et al.  Monitoring recombinant human interferon‐gamma N‐glycosylation during perfused fluidized‐bed and stirred‐tank batch culture of CHO cells , 1998, Biotechnology and bioengineering.

[11]  U von Stockar,et al.  On-line determination of animal cell concentration in two industrial high-density culture processes by dielectric spectroscopy. , 2002, Biotechnology and bioengineering.

[12]  C. Hoy,et al.  Multiple cell culture factors can affect the glycosylation of Asn-184 in CHO-produced tissue-type plasminogen activator. , 2000, Biotechnology and bioengineering.

[13]  K Konstantinov,et al.  Fermentor temperature as a tool for control of high-density perfusion cultures of mammalian cells. , 1997, Biotechnology and bioengineering.

[14]  E. Lüllau,et al.  Comparison of Batch and Perfusion Culture in Combination with Pilot‐Scale Expanded Bed Purification for the Production of Soluble Recombinant β‐Secretase , 2003, Biotechnology progress.

[15]  James M Piret,et al.  Scale‐up and optimization of an acoustic filter for 200 L/day perfusion of a CHO cell culture , 2002, Biotechnology and bioengineering.

[16]  W M Miller,et al.  A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: Effect of nutrient concentration, dilution rate, and pH , 2000, Biotechnology and bioengineering.

[17]  H. Blanch,et al.  A kinetic analysis of hybridoma growth and metabolism in continuous suspension culture on serum‐free medium , 1991, Biotechnology and bioengineering.

[18]  Investigation of parameters affecting a fixed bed bioreactor process for recombinant cell lines , 2004, Cytotechnology.

[19]  A. Bull,et al.  N‐glycans of recombinant human interferon‐γ change during batch culture of chinese hamster ovary cells , 1995 .

[20]  Charles F. Goochee,et al.  Environmental Effects on Protein Glycosylation , 1990, Bio/Technology.

[21]  U von Stockar,et al.  Monitoring of temperature effects on animal cell metabolism in a packed bed process. , 2002, Biotechnology and bioengineering.

[22]  R. E. Spier,et al.  Some myths and messages concerning the batch and continuous culture of animal cells , 1997, Cytotechnology.

[23]  M. Butler,et al.  Erythropoietin production from CHO cells grown by continuous culture in a fluidized-bed bioreactor. , 2002, Biotechnology and bioengineering.

[24]  A. Bull,et al.  The effect of the dilution rate on CHO cell physiology and recombinant interferon‐γ production in glucose‐limited chemostat culture , 1993, Biotechnology and bioengineering.

[25]  Wei-Shou Hu,et al.  High density culture of mammalian cells with dynamic perfusion based on on-line oxygen uptake rate measurements , 2004, Cytotechnology.

[26]  Alain Van Dorsselaer,et al.  Glycosylation of human recombinant gonadotrophins: characterization and batch-to-batch consistency. , 2003, Glycobiology.

[27]  C. Goochee,et al.  The Oligosaccharides of Glycoproteins: Bioprocess Factors Affecting Oligosaccharide Structure and their Effect on Glycoprotein Properties , 1991, Bio/Technology.

[28]  H. Blanch,et al.  Continuous hybridoma suspension cultures with and without cell retention: kinetics of growth, metabolism and product formation. , 1992, Journal of biotechnology.